NOTE: THIS GUIDANCE DOCUMENT HAS BEEN ARCHIVED BECAUSE MORE CURRENT INFORMATION CAN BE FOUND ON THE NIH WEBSITE AT http://grants.nih.gov/archive/grants/policy/nihgps_2001/part_iia_2.htm.
June 1, 1994
Subject: AWARDEE COMPLIANCE WITH 45 CFR 46 REQUIREMENTS
Dear Colleague:
This bulletin is being forwarded to PHS Components
and other parts of DHHS that are involved in research activities
that include human subjects. Its purpose is to clarify when a potential awardee (applicant
institution) of a grant, contract, or cooperative agreement must
initiate action to have its proposed project reviewed by an Institutional
Review Board (IRB) and obtain approval of an Assurance
from the Office for Protection from Research Risks (OPRR) as
specified in 45 CFR 46.103.
Institutions that do not have an OPRR-approved
Multiple Project Assurance (MPA) are required to have an IRB review
and prepare an Assurance document for compliance with 45 CFR 46 only after the
appropriate Program office has determined that the project will
be funded. The Program Office and the Awards Office are authorized
to request from OPRR negotiation of a Single Project Assurance
(SPA). An SPA includes provision for certification of IRB review. OPRR
will then send to the applicant institution a letter with explanatory
and sample material. An Assurance is not required for grant, contract,
or cooperative agreement applications before peer review - unless
the project has been designated for expedited peer review (such
as some AIDS projects). Section 45 CFR 46.103 (5) (f) specifies
that an applicant institution (without an MPA) has 30 days after
receipt of a request (from OPRR) to certify that its application
or proposal has been approved by an IRB (full board review), and
to complete an appropriate Assurance, as specified by OPRR. Therefore,
please do not unnecessarily require of either the investigator
or the awardee institution a Form 310 (formerly Form 596) for
certification of IRB review, or an Assurance before peer review.
Such untimely requirements cause avoidable stress for the applicant
and numerous unnecessary telephone calls to OPRR.
The regulations [45 CFR 46.103 (5) (f) ] indicate
that MPA institutions must submit certification of IRB review
and approval with the
application or proposal or by such later date as may be prescribed
by the Department or Agency to which the application or proposal
is submitted. NIH has determined that it will allow MPA institutions
to submit certification of IRB review and approval 60 days after
the submission of its application or by the date of the peer review
meeting, whichever is shorter. The Form 596 is not included in
the application kits anymore, so you may accept a letter certifying
IRB review when appropriate or the new Form 310.
Your attention to this important matter is greatly
appreciated.
|
Melody Lin, Ph.D. Director Division of Human Subject Protections Office for Protection from Research Risks |
Gary Ellis, Ph.D. Director Office for Protection from Research Risks |